Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells

Por Schardt, John S., Oubaid, Jinan M., Williams, Sonya C., Howard, James L., Aloimonos, Chloe M., Bookstaver, Michelle L., Lamichhane, Tek N., Sokic, Sonja, Liyasova, Mariya S., O’Neill, Maura, Andresson, Thorkell, Hussain, Arif, Lipkowitz, Stanley, Jay, Steven M.
Publicado no Mol Pharm (2017)